Research News
View articles by month and year
-
Ginger May Help Ease Nausea Immediately After Chemotherapy
A small study suggests that adding ginger to standard anti-nausea medicines can reduce nausea in women diagnosed with advanced-stage breast cancer immediately after chemotherapy more than the anti-nausea medicines alone.
-
Use of Anthracyclines to Treat Breast Cancer Has Gone Down
A study has found that after 2005, there was a large increase in taxane chemotherapy and a decrease in anthracycline chemotherapy to treat breast cancer in the United States.
-
Chemo During Pregnancy Appears Safe for Mother and Child
A study supports other research that suggests chemotherapy during pregnancy doesn't have harmful effects on the baby.
-
Research Suggests How Metastatic Cancer Becomes Resistant to Chemotherapy
A very early study on cancer cells in petri dishes in the lab has found that a type of cell called a fibroblast also is damaged by chemotherapy. Damaged fibroblasts make a protein called WNT16B that may help metastatic cancer cells become resistant to chemotherapy and grow.
-
Cymbalta Helps Ease Neuropathy Caused by Chemo
A study has found that most people with peripheral neuropathy got some relief from the antidepressant medicine Cymbalta.
-
T-DM1 Works Better on Advanced-Stage, HER2-Positive Cancer Than Standard Meds
A study found that women diagnosed with advanced-stage, HER2-positive breast cancer that had stopped responding to a standard regimen lived longer without the cancer growing when they got the experimental medicine T-DM1 compared to women who got a different regimen.
-
Experimental T-DM1 May Help Treat Advanced-Stage, HER2-Positive Disease
In a preliminary study, women with HER2-positive locally advanced or metastatic breast cancer treated with the targeted therapy T-DM1 lived longer without the cancer showing signs of progression compared to similar women who received a standard treatment combination of Herceptin (chemical name: trastuzumab) and Taxotere (chemical name: docetaxel).
-
FDA Approves Generic Taxotere
The FDA has approved a generic form of Taxotere, which may lower treatment costs.
-
Halavan May Help Treat Metastatic Disease
Women diagnosed with metastatic breast cancer that didn't respond to other treatments who got Halavan lived 2 months longer than women who got supportive care or a standard metastatic cancer treatment.
-
Xeloda Doesn’t Seem to Reduce Recurrence Risk
A new study shows that the risk of recurrence is the same whether or not Xeloda was added to a standard adjuvant chemotherapy regimen for early-stage breast cancer with a high risk of recurrence.
